Level 1 strategies, % | Level 3 strategies, % | P value | |
---|---|---|---|
Overall | 82 | 43 | < 0.001 |
Clinical vignette scenario | |||
Community acquired pneumonia | 93 | 25 | < 0.001 |
Acute coronary syndrome* | 93 | 65 | < 0.001 |
Congestive heart failure | 85 | 31 | < 0.001 |
Syncope | 83 | 33 | < 0.001 |
Asthma* | 81 | 52 | < 0.001 |
End-Stage lung cancer*† | 77 | 61 | 0.01 |
Transient ischemic attack*† | 73 | 17 | < 0.001 |
Chronic obstructive pulmonary disease*† | 69 | 57 | 0.08 |